GLP1Compass
Information & advocacy — not medical advice. We don't sell the drug; we help you afford it. Figures current as of June 2026.

What is the appeal process for GLP-1 medication denials?

VERIFIED FROM SOURCES

Understanding the appeal process can help you navigate insurance denials for GLP-1 medications.

Understanding the Appeal Process

If your request for GLP-1 medication is denied by your insurance, there is a structured appeal process you can follow. This process typically involves several steps, known as the appeal ladder. The first step is an internal appeal where you submit a letter of medical necessity that ties your documented medical record to each criterion required by your plan.

The second step is a peer-to-peer review, where your prescriber speaks directly with the plan's medical director to advocate for your case. If the denial persists, you can proceed to a second internal appeal, which may require additional documentation if newly available.

If all internal appeals are exhausted, you can seek an external review from an independent review organization. This is a neutral third party that can help determine whether the denial was justified based on benefit exclusion versus medical necessity. It's important to note that if the denial is due to a hard benefit exclusion—meaning the plan does not cover weight-loss drugs at all—appeals are unlikely to change the outcome. In such cases, you may need to pivot to a covered indication, explore the Medicare Bridge, or consider a cash-pay option.